Scott G. Ginn is CFO at AMEDISYS INC (AMED). They have made 25 open-market trades across 2 companies since 2012, most recently 2026-01-21.
CIK 0001543701
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $201K since 2024, against 24 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ISTR | BUY | 2024-11-22 | 2024-11-25 | $23.68 | $201K | -3.2% | -8.8% | -24.1% |
| AMED | SELL | 2021-05-28 | 2021-06-02 | $261.60 | $510K | +2.7% | +4.7% | -27.4% |
| AMED | SELL | 2021-04-30 | 2021-05-04 | $283.33 | $552K | -0.7% | -3.7% | +0.1% |
| AMED | SELL | 2021-03-31 | 2021-04-02 | $260.40 | $508K | +2.4% | -3.0% | -3.4% |
| AMED | SELL | 2021-02-26 | 2021-03-02 | $264.15 | $515K | +6.1% | +7.3% | +2.8% |
| AMED | SELL | 2021-01-29 | 2021-02-02 | $286.87 | $559K | +7.2% | -17.9% | -9.0% |
| AMED | SELL | 2020-12-31 | 2021-01-05 | $287.57 | $561K | +2.0% | +2.8% | -4.8% |
| AMED | SELL | 2020-11-30 | 2020-12-02 | $241.62 | $471K | +9.3% | +17.1% | +2.2% |
| AMED | SELL | 2020-10-30 | 2020-11-03 | $250.00 | $244K | -8.2% | -7.3% | +8.4% |
| AMED | SELL | 2020-09-30 | 2020-10-02 | $230.79 | $450K | +7.1% | +8.8% | +25.4% |
| AMED | SELL | 2020-09-04 | 2020-09-09 | $236.44 | $231K | +3.7% | +7.0% | +12.9% |
| AMED | SELL | 2020-05-05 | 2020-05-07 | $175.30 | $2.3M | +9.0% | +2.0% | +33.8% |
| AMED | SELL | 2020-02-21 | 2020-02-24 | $194.11 | $3.7M | -12.4% | -15.7% | -1.9% |
| AMED | SELL | 2019-11-06 | 2019-11-08 | $145.17 | $1.1M | +3.9% | +11.6% | +26.7% |
| AMED | SELL | 2019-11-06 | 2019-11-08 | $145.17 | $1.1M | +3.9% | +11.6% | +26.7% |
| AMED | SELL | 2019-08-05 | 2019-08-07 | $132.19 | $1.2M | -0.4% | +1.4% | +10.2% |
| AMED | SELL | 2019-06-10 | 2019-06-12 | $118.50 | $577K | +3.1% | +4.1% | +12.9% |
| AMED | SELL | 2018-11-12 | 2018-11-14 | $117.39 | $709K | +5.6% | +6.0% | +15.8% |
| AMED | SELL | 2018-11-12 | 2018-11-14 | $117.41 | $897K | +5.6% | +6.0% | +15.8% |
| AMED | SELL | 2018-06-07 | 2018-06-11 | $78.44 | $1.2M | +7.5% | +13.9% | +51.6% |
| AMED | SELL | 2017-05-08 | 2017-05-10 | $58.62 | $2.8M | +0.2% | +8.4% | -15.8% |
| AMED | SELL | 2016-05-11 | 2016-05-13 | $51.61 | $292K | +2.5% | -0.1% | -2.9% |
| AMED | SELL | 2016-05-11 | 2016-05-13 | $51.62 | $310K | +2.5% | -0.1% | -2.9% |
| AMED | SELL | 2015-08-07 | 2015-09-25 | $46.33 | $142K | -6.2% | +0.9% | +0.9% |
| AMED | SELL | 2012-08-14 | 2012-08-14 | $14.37 | $36K | -6.2% | +0.9% | +0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.